Clinical Significance of Neuregulin 4, Afamin, and SERPINB1 in Gestational Diabetes Mellitus and Their Relationship with Insulin Resistance

<div>The diagnostic effect of AFM, SERPINB1, and NRG4 serum levels in GDM. ROCs for afamin (AFM) concentrations showed an AUC of 0.629 (95% CI: 0.527∼0.731, (a)) of 0.832 (95% CI: 0.754∼0.909, (b)) for the serpin family B member 1 (SERPINB1) serum level, of 0.626 (95% CI: 0.524∼0.728, (c)) for the neuregulin 4 (NRG4) serum level, and of 0.839 (95% CI: 0.764∼0.913, (d)) for the combined detection of AFM, SERPINB1, and NRG4 serum levels.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Clinical Significance of Neuregulin 4, Afamin, and SERPINB1 in Gestational Diabetes Mellitus and Their Relationship with Insulin Resistance 

Figure 2 | Clinical Significance of Neuregulin 4, Afamin, and SERPINB1 in Gestational Diabetes Mellitus and Their Relationship with Insulin Resistance 